Advertisement
Research Article

Lymphotoxin-α Gene and Risk of Myocardial Infarction in 6,928 Cases and 2,712 Controls in the ISIS Case-Control Study

  • Robert Clarke equal contributor mail,

    equal contributor Contributed equally to this work with: Robert Clarke, Peng Xu

    To whom correspondence should be addressed. E-mail: robert.clarke@ctsu.ox.ac.uk

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Peng Xu equal contributor,

    equal contributor Contributed equally to this work with: Robert Clarke, Peng Xu

    Affiliation: Centre National de Genotypage, Paris, France

    X
  • Derrick Bennett,

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Sarah Lewington,

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Krina Zondervan,

    Affiliation: Wellcome Trust Centre for Human Genetics, Old Road Campus, Oxford, United Kingdom

    X
  • Sarah Parish,

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Alison Palmer,

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Sarah Clark,

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Lon Cardon,

    Affiliation: Wellcome Trust Centre for Human Genetics, Old Road Campus, Oxford, United Kingdom

    X
  • Richard Peto,

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Mark Lathrop,

    Affiliation: Centre National de Genotypage, Paris, France

    X
  • Rory Collins, for the International Study of Infarct Survival (ISIS) Collaborators

    Affiliation: Clinical Trial Service Unit, Old Road Campus, Oxford, United Kingdom

    X
  • Published: July 07, 2006
  • DOI: 10.1371/journal.pgen.0020107

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.